Authors


Christina L. Boisseau, MA

Latest:

Development of a Transdiagnostic Unified Psychosocial Treatment for Emotional Disorders

Research emerging from the field of emotion science suggests that individuals who have anxiety and mood disorders tend to experience negative affect more frequently and more intensely than do healthy individuals, and they tend to view these experiences as more aversive, representing a common diathesis across anxiety and mood disorders.1-5 Deficits in the ability to regulate emotional experiences, resulting from unsuccessful efforts to avoid or dampen the intensity of uncomfortable emotions, have also been found across the emotional disorders and are a key target for therapeutic change.


Christina L. Wichman, DO

Latest:

Speaking Up: Sexual Harassment in the Medical Setting

Here: a review of the definition of sexual harassment, its prevalence among physicians and medical students, its potential impact on physicians and trainees, and guidance about its management.


Christina S. Won, PharmD, PhD

Latest:

Mini Quiz: Dietary Effects of Psychiatric Drugs

How do foods containing tyramine (eg, aged cheeses, fermented foods, cured meats) interact with some psychiatric medications?


Christina Scribner, MS, RDN, CEDRD, CSSD

Latest:

Mini Quiz: Eating Disorders and Brain Function

What does the evidence tell us about the effect of eating disorders on brain function? Take the quiz and learn more.


Christina Thomas, MSSW

Latest:

Underdiagnosing and Overdiagnosing Psychiatric Comorbidities

Diagnostic assessment of psychiatric disorders and their comorbidities is a challenge for many clinicians. In emergency settings, there is no time to conduct lengthy interviews, and collateralinformation is often unavailable.


Christine E. Marx, MD

Latest:

Neurosteroids and Psychiatric Disorders

Although many of the physiological functions of neurosteroids are currently unknown, evidence suggests that these endogenous molecules may play a role in the pathophysiology of psychiatric disorders and treatment strategies. Neurosteroids have been linked to SSRI action and may be relevant to antipsychotic drug effects. Do neurosteroids have neuroprotective properties or HPA axis effects?


Christine E. Ryan, PhD

Latest:

Atypical Antipsychotic Augmentation in the Treatment of Depression

Despite the clinician's goal of treating the depressed patient to the point of remission, this state is generally achieved in only 15% to 30% of patients. Another 10% to 30% of patients respond poorly to antidepressant treatment, while 30% to 40% have a remitting and relapsing course.1 Patients without a major depressive disorder are likely to be treated successfully by primary care physicians and/or other mental health professionals, which leaves psychiatrists to treat patients who have forms of depression that are less responsive to treatment.


Christine Moutier, MD
Christine Yu Moutier, MD

Latest:

Preventing Clinician Suicide

Although the practice of medicine can be immensely rewarding, it also can be extraordinarily stressful. Here's how we can help prevent clinician suicide.


Christine Shapter, MD

Latest:

Depression and Anxiety in Cardiac Disease

Here: a look at the associations between negative psychological states and CV health, physiologic and health behavior mechanisms, and ways to diagnose and treat depression and anxiety disorders.


Christoph U. Correll, MD

Latest:

Cognitive Impairment and Upcoming Agents for Long-Acting Schizophrenia Treatment

For the past 7 decades, there has only been 1 mechanism of action for schizophrenia treatment. Christoph Correll, MD, talks new options and cognitive impairment at the 2024 APA Annual Meeting.


Christopher Aloezos, MD

Latest:

The Butterfly Effect: An Interview With Jon Ronson

While ostensibly The Butterfly Effect tells the story behind the wide availability of free internet pornography, the psychiatrist listener will quickly appreciate that this is only the beginning of the story.


Christopher D. Webster, PhD

Latest:

Violence Risk Assessment in Everyday Psychiatric Practice

Hy Bloom provided an expert psychiatric report in a multiple murder case in which the accused, who had schizophrenia and depression, had killed his wife and 2 children. Before the murders, the accused had been seeing a psychiatrist and family physician for treatment of the mental disorders.


Christopher Daley, MD

Latest:

Working With Transgender Persons

Using a question-and-answer format, we present a brief overview of issues that arise when mental health professionals explore how to best serve this population.


Christopher Ferguson, PhD

Latest:

New Evidence Suggests Media Violence Effects May Be Minimal

New research over the past decade has suggested that links between media violence and child aggression are less clear than previously thought. How has our understanding of media violence effects changed?


Christopher G. Fichtner, MD

Latest:

Medical Marijuana and Mental Health: Cannabis Use in Psychiatric Practice

Here's why psychiatrists and other mental health professionals need to understand the relationship between cannabis and mental disorders.


Christopher Gordon, MD

Latest:

Shared Decision Making in the Treatment of Psychosis

Psychiatrists vary in their eagerness to share therapeutic decisions with patients: some believe that adherence is paramount and paternalism is often necessary to prevent loss of insight with consequent impaired judgment and functional decline. These authors argue in favor of a radically more collaborative style.


Christopher I. Eckhardt, PhD

Latest:

Interventions for Perpetrators of Intimate Partner Violence

Substantial progress has been made in the development of etiologic models of intimate partner violence and interventions for individuals who assault their intimate partners. These authors provide details.


Christopher J. Hammond, MD

Latest:

Adolescent Marijuana Use and Vulnerability for Neuropsychiatric Disorders

An overview of some of the recent scientific data examining the relationship between adolescent marijuana use and later onset of neuropsychiatric disorders.


Christopher J. Hammond, MD, PhD

Latest:

8 Core Principles When Treating Addiction in Adolescents

The main goal in treating addiction is to help the patient achieve and improve functioning. When that patient is also an adolescent, there are special considerations. Here's a quick primer.


Christopher J. Kratochvil, MD

Latest:

Your Child in the Balance: An Insider's Guide for Parents to the Psychiatric Medicine Dilemma

Your Child in the Balance provides parents with a unique and insightful look into the role of psychotropic medications in the treatment of children and adolescents. Dr Kalikow does a stellar job of systematically and comprehensively addressing this complex and provocative topic in this guide for parents from the perspective of a practicing child and adolescent psychiatrist.


Christopher J. McDougle, MD

Latest:

Behavioral and Pharmacologic Treatment of Aggression in Children With Autism

This article will provide an overview of treatment modalities, with emphasis on the future direction of interventions targeting aggression in children with autism.


Christopher J. Patrick, PhD

Latest:

Psychobiological Aspects of Antisocial Personality Disorder, Psychopathy, and Violence

The key focus is on understanding violent offending (eg, reactive, proactive, firearm violence) tied to antisocial personality disorder and psychopathy using a psychobiological lens.


Christopher J. Ryan, MBBS

Latest:

Ethics, Psychiatry, and End-of-Life Issues

At the end of life, psychiatrists are often asked to assess a patient’s capacity to refuse treatment, but the role of the psychiatrist in this situation is much broader.


Christopher K. Peters, MD

Latest:

Understanding and Managing Adolescent Disruptive Behavior

The words attributed to Socrates resonate with the perspectives of many contemporary parents and clinicians.1 The endurance of the concern suggests something fundamental about the psychopathology of deviant, disruptive behavior of youth. Yet clinicians struggle to understand its origins, to help parents control their children, and to help the children control themselves. Clinically, this manifests in failed pharmacological treatments, incompleted courses of individual therapy, problems in engaging families in treatment, and controversies over which therapy is most effective.


Christopher Kenney, MD

Latest:

Levodopa-Induced Dyskinesia: Medical and Surgical Management

In the 1960s, the treatment of Parkinson disease (PD) was revolutionized by the introduction of levodopa. Soon after its discovery, however, it was observed that continuous treatment was complicated by the emergence of choreoathetoid movements and off episodes.


Christopher Koppen

Latest:

Outlook for Federal Mental Health Policy in the 115th Congress

Will the new Administration disrupt mental health coverage in this country?


Christopher Lange, MD

Latest:

Introduction: Serving Those Who Serve

This Special Report aims to address those symptoms and syndromes most commonly seen by clinicians who treat service members. The 5 articles of the Special Report cover the most challenging aspects of their care, and the authors hope to expand the reader’s understanding of the recent conflicts’ tragic consequences.


Christopher Lee, MD

Latest:

The Clinical Management of Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a progressive, debilitating, fatal disease that involves degeneration of upper and lower motor neurons. Patients often initially present with limb or bulbar weakness, atrophy, and spasticity, followed by progressive loss of ambulation and, ultimately, respiratory failure, which is the most common cause of death.


Christopher Lockey, MD

Latest:

Practice Management: Managing Risks When Practicing in Three-Party Care Settings

Following trends in medicine, psychiatry is faced with limited resources and third-party administration of resource allocation. This has affected psychiatric practice in many ways and altered the doc-tor-patient relationship. Trends toward resource-sensitive, third-party–related psychiatric practice may be accelerated by the current social concerns regarding the economy. Thus, an awareness of social context and the growing recognition that autonomy-enhancing alternatives to paternalistic care are fundamental to improve both the effectiveness and accessibility of care in limited-resource environments are each becoming vital for an informed clinical and risk-management practice perspective.1


Christopher M. Celano, MD

Latest:

Positivism and Heart Health: Issues for Psychiatrists

Psychiatrists are uniquely suited to help patients with and without heart disease feel more positive and hopeful. This, in turn, can have substantial effects not just on mental health, but on health behaviors and physical health outcomes as well.

© 2024 MJH Life Sciences

All rights reserved.